Bulk Manufacturer of Controlled Substances Registration, 21813 [2019-10025]

Download as PDF 21813 Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices Dated: April 27, 2019. John J. Martin, Assistant Administrator. DEPARTMENT OF JUSTICE Controlled substance Drug Enforcement Administration [FR Doc. 2019–10028 Filed 5–14–19; 8:45 am] [Docket No. DEA–392] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Importer of Controlled Substances Application: S & B Pharma, Inc Drug Enforcement Administration ACTION: [Docket No. DEA–392] DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 14, 2019. Such persons may also file a written request for a hearing on the application on or before June 14, 2019. Bulk Manufacturer of Controlled Substances Registration ACTION: Notice of registration. The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I controlled substances. SUMMARY: The company listed below has applied to be registered as a bulk manufacturer of various basic classes of controlled substances. Information on the previously published notice is listed below. No comments or objections were submitted for the notice. Company FR docket 84 FR 2579 Published February 7, 2019 jbell on DSK3GLQ082PROD with NOTICES The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic class of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed company. Dated: April 27, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–10025 Filed 5–14–19; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 22:43 May 14, 2019 Jkt 247001 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: SUPPLEMENTARY INFORMATION: Kinetochem, LLC .............. Notice of application. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on December 24, 2018, S & B Pharma, Inc., dba: Norac Pharma, 405 South Motor Avenue, Azusa, California 91702–3232 applied to be registered as an importer of the following basic class of controlled substances: SUPPLEMENTARY INFORMATION: PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 4-Anilino-N-phenethyl-4piperidine (ANPP). Tapentadol ..................... Drug code Schedule 8333 II 9780 II The company plans to import the listed controlled substances in bulk for the manufacture of controlled substances for distribution to its customers. Dated: April 27, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–10008 Filed 5–14–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: AndersonBrecon, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 14, 2019. Such persons may also file a written request for a hearing on the application on or before June 14, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been DATES: E:\FR\FM\15MYN1.SGM 15MYN1

Agencies

[Federal Register Volume 84, Number 94 (Wednesday, May 15, 2019)]
[Notices]
[Page 21813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10025]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and been granted a 
registration by the Drug Enforcement Administration (DEA) as a bulk 
manufacturer of various classes of schedule I controlled substances.

SUPPLEMENTARY INFORMATION: The company listed below has applied to be 
registered as a bulk manufacturer of various basic classes of 
controlled substances. Information on the previously published notice 
is listed below. No comments or objections were submitted for the 
notice.

------------------------------------------------------------------------
             Company                   FR docket          Published
------------------------------------------------------------------------
Kinetochem, LLC..................  84 FR 2579......  February 7, 2019
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of this registrant to manufacture the 
applicable basic class of controlled substances is consistent with the 
public interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. The DEA 
investigated the company's maintenance of effective controls against 
diversion by inspecting and testing the company's physical security 
systems, verifying the company's compliance with state and local laws, 
and reviewing the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed company.

    Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10025 Filed 5-14-19; 8:45 am]
 BILLING CODE 4410-09-P